Shortage Avoided

IMITREX INJECTION 12MG/ML

GLAXOSMITHKLINE INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of IMITREX INJECTION 12MG/ML in Canada?

Not currently. The most recent shortage report for IMITREX INJECTION 12MG/ML is marked resolved (last updated March 29, 2017).

Can I still get this?Check with your pharmacist

StatusShortage Avoided

Same-ingredient products on fileNone found

Affected strength12MG

Last updated2017-03-29

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02212188

Strength

12MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS

Active Ingredient

SUMATRIPTAN

Tier

Unrated

Last Updated

2017-03-29

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GLAXOSMITHKLINE INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

DIN 02245127

DIN 02245126

DIN 02240835

DIN 02240836

DIN 02240837

1MG · DIN 02237820